5 (352) In stock
Download scientific diagram | Illustration of the tumur microenvironment in triple-negative breast cancer. Notes: Data from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC? Adapted from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC. Eur Rev Med Pharmacol Sci. 2021;25(7):2885-2897. Creative Commons. 7 from publication: Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management | Triple negative breast cancer (TNBC) is a subtype of breast cancer which does not express or expresses a minimum amount of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) protein. TNBCs include a heterogenic group of | Breast Cancer Management, Triple Negative Breast Neoplasms and Tumor-Infiltrating Lymphocytes | ResearchGate, the professional network for scientists.
Repurposed drug shows improved results with combined therapy for triple negative breast cancer
PDF] A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Cancers, Free Full-Text
Tumor microenvironment in the body
Stromal cells affect immune infiltrate in triple-negative breast cancer
Targeting adenosine receptor 2B in triple negative breast cancer
Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance - ScienceDirect
Frontiers The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment - ScienceDirect
FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer
Vaccines, Free Full-Text
Oncology: Leading the way in genomics and precision medicine based therapies
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches
Schematic illustration of pH activation of nanoparticle by tumor